News for SomaLogic, Inc. (SLGC)

SOUTH SAN FRANCISCO, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. ( LAB) (the ”œCompany” or ”œStandard BioTools”) today announced fi

**media[551520]**

**media[509161]**

**media[496616]**

Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024...

A Yahoo Finance report on September 28 reveals that consumers are beginning to feel the effects of a cooling labor market, according to the latest Consumer Confidence Index, which shows a narrowing gap...

Casdin Partners master fund buys Standard Biotools shares worth over $546k

Earnings call: 10x Genomics adjusts 2024 guidance amid macro pressures

Illumina, Inc. (NASDAQ:NASDAQ:ILMN) Bernstein Strategic Decisions Conference May 29, 2024 9:00 AM ETCompany ParticipantsAnkur Dhingra - Chief Financial...

SOUTH SAN FRANCISCO, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (

Earnings call: Standard BioTools achieves growth and synergy targets in Q1

Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024

The Global Aptamers Market Size was Valued at USD 2.86 Billion in 2023 and the Worldwide Aptamers Market Size is Expected to Reach USD 17.3 Billion by...

Standard BioTools completes merger with SomaLogic

Establishes Leading Platform of Complementary Multi-omic Technologies with Enhanced Scale and Commercial Reach; Strengthened Balance Sheet to Self-Fund...

BOULDER, Colo., Dec. 28, 2023 /PRNewswire/ -- Dr. Larry Gold, the founder of SomaLogic, Inc. and Dr. Jason Cleveland, SomaLogic's current Chief Technology Officer, are issuing the below letter to...

Highlights Public Opposition to Proposed Merger from Skye Fund III, a Long-Term SomaLogic Investor Deeply Troubled by Information in Complaint Filed by Company Founder and Chief Technology Officer...

Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter financial results. Quanex Building Products shares fell 10.7% to $30.95 on Friday.

Files Preliminary Proxy Statement to Solicit Shareholders to Oppose the Merger Intends to Vote AGAINST the Conflict-Plagued and Excessively Dilutive Transaction, Which Stands to Unduly Benefit...